To the editor

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

West WH, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB and Oldham RK (1987) Constant-infusion recombinant Interleukin-2 in adoptive immunotherapy of advanced cancer. N. Engl. J. Med. 316: 898–905.
Google Scholar
Rosenberg SA, Lotze ML, Muul LM, Chang AE, Avis FP, Leitman S, Linehan M, Robertson CN, Lee RE, Rubin JI, Seipp CA, Simpson CG and White DE (1987) A progress report on the treatment of 157 patents with advanced cancer using lymphokine activated killer cells and Interleukin-2 or high dose Interleukin-2 alone. N. Engl. J. Med. 316: 889–897.
Google Scholar
Moertel CG (1986) On lymphokines, cytokines, and breakthroughs. JAMA 256: 3141.
Google Scholar
Yannelli JR, Thurman GB, Dickerson SG, Mrowca A, Sharp E and Oldham RK (1987) An improved method for the generation of human lymphokine activated killer cells. J. Immunol. Met. 100: 137–145.
Google Scholar

Biotherapeutics, Inc., Riverside Drive, 37064, Franklin, Tennessee, USA
John R. Yannelli, Ann Mrowca Bastin & Martin Jadus

Authors

John R. Yannelli
View author publications
You can also search for this author in PubMed Google Scholar
Ann Mrowca Bastin
View author publications
You can also search for this author in PubMed Google Scholar
Martin Jadus
View author publications
You can also search for this author in PubMed Google Scholar

Yannelli, J.R., Bastin, A.M. & Jadus, M. To the editor. Cytotechnology 1, 183–184 (1988). https://doi.org/10.1007/BF00146820

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.